Boehringer forms new alliance to develop gene therapy
Boehringer Ingelheim has entered a global partnership with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), Imperial Innovations and Oxford…
Boehringer Ingelheim
-
-
Boehringer Ingelheim acquires MabVax’s programme for solid tumours
Boehringer Ingelheim has entered an asset acquisition and licence agreement for US-based biotechnology firm MabVax Therapeutics’ programme designed to target…
-
Boehringer expands drug manufacturing capabilities in China
Boehringer Ingelheim has added a new filling line to its Oasis facility in Shanghai, China in order to expand and…
